Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Crystal M Cooper

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Journal of Affective Disorders|August 29, 2025
Longitudinal symptom-based clinical profiles in depressed individuals linked to salience network: findings from the Texas resilience against depression studyCherise R Chin Fatt, Jane A Foster, Taryn L Mayes, et al.
Biological Psychiatry|June 9, 2022
Dynamic Resting-State Network Biomarkers of Antidepressant Treatment ResponseRoselinde H Kaiser, Henry W Chase, Mary L Phillips, et al.
The American Journal of Psychiatry|September 21, 2019
Effect of Intrinsic Patterns of Functional Brain Connectivity in Moderating Antidepressant Treatment Response in Major DepressionCherise R Chin Fatt, Manish K Jha, Crystal M Cooper, et al.
Journal of Psychiatric Research|January 10, 2020
Comprehensive phenotyping of depression disease trajectory and risk: Rationale and design of Texas Resilience Against Depression study (T-RAD)Madhukar H Trivedi, Cherise R Chin Fatt, Manish K Jha, et al.
Magnetic Resonance Imaging|September 11, 2017
Test-retest reliability of cerebral blood flow in healthy individuals using arterial spin labeling: Findings from the EMBARC studyJorge R C Almeida, Tsafrir Greenberg, Hanzhang Lu, et al.
Depression and Anxiety|October 20, 2015
A COMPREHENSIVE EXAMINATION OF WHITE MATTER TRACTS AND CONNECTOMETRY IN MAJOR DEPRESSIVE DISORDERDoreen M Olvet, Lauren Delaparte, Fang-Cheng Yeh, et al.
Psychological Medicine|November 20, 2020
Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trialYuen-Siang Ang, Gerard E Bruder, John G Keilp, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 30, 2018
Pretreatment and early-treatment cortical thickness is associated with SSRI treatment response in major depressive disorderElizabeth A Bartlett, Christine DeLorenzo, Priya Sharma, et al.
Molecular Psychiatry|August 8, 2019
Discovery and replication of cerebral blood flow differences in major depressive disorderCrystal M Cooper, Cherise R Chin Fatt, Peiying Liu, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 13, 2015
Neural Correlates of Three Promising Endophenotypes of Depression: Evidence from the EMBARC StudyChristian A Webb, Daniel G Dillon, Pia Pechtel, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Affective Disorders|August 29, 2025
Longitudinal symptom-based clinical profiles in depressed individuals linked to salience network: findings from the Texas resilience against depression studyCherise R Chin Fatt, Jane A Foster, Taryn L Mayes, et al.
Biological Psychiatry|June 9, 2022
Dynamic Resting-State Network Biomarkers of Antidepressant Treatment ResponseRoselinde H Kaiser, Henry W Chase, Mary L Phillips, et al.
The American Journal of Psychiatry|September 21, 2019
Effect of Intrinsic Patterns of Functional Brain Connectivity in Moderating Antidepressant Treatment Response in Major DepressionCherise R Chin Fatt, Manish K Jha, Crystal M Cooper, et al.
Journal of Psychiatric Research|January 10, 2020
Comprehensive phenotyping of depression disease trajectory and risk: Rationale and design of Texas Resilience Against Depression study (T-RAD)Madhukar H Trivedi, Cherise R Chin Fatt, Manish K Jha, et al.
Magnetic Resonance Imaging|September 11, 2017
Test-retest reliability of cerebral blood flow in healthy individuals using arterial spin labeling: Findings from the EMBARC studyJorge R C Almeida, Tsafrir Greenberg, Hanzhang Lu, et al.
Depression and Anxiety|October 20, 2015
A COMPREHENSIVE EXAMINATION OF WHITE MATTER TRACTS AND CONNECTOMETRY IN MAJOR DEPRESSIVE DISORDERDoreen M Olvet, Lauren Delaparte, Fang-Cheng Yeh, et al.
Psychological Medicine|November 20, 2020
Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trialYuen-Siang Ang, Gerard E Bruder, John G Keilp, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 30, 2018
Pretreatment and early-treatment cortical thickness is associated with SSRI treatment response in major depressive disorderElizabeth A Bartlett, Christine DeLorenzo, Priya Sharma, et al.
Molecular Psychiatry|August 8, 2019
Discovery and replication of cerebral blood flow differences in major depressive disorderCrystal M Cooper, Cherise R Chin Fatt, Peiying Liu, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 13, 2015
Neural Correlates of Three Promising Endophenotypes of Depression: Evidence from the EMBARC StudyChristian A Webb, Daniel G Dillon, Pia Pechtel, et al.
Pageof 3